In the second FSGS group we found a significant increase in urinary excretion of complement components C4b, C9, as well as factor B, I and a decrease in CD59, an inhibitor of the membrane attack complex, which indicates the possible role of complement activation associated with stronger damage. This evidence concerns the gene C9 and focal segmental glomerulosclerosis.